| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |